Autism and Vitamin D – 3 biomarkers found so far – March 2018

In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D

Metabolic Brain Disease, pp 1–15, https://doi.org/10.1007/s11011-018-0199-1
Afaf El-Ansary John J. Cannell Geir Bjørklund, Ramesa Shafi Bhat Abeer M. Al Dbass Hanan A. Alfawaz Salvatore Chirumbolo Laila Al-Ayadhi

Autism spectrum disorder (ASD) affects about 1% of the world’s population. Vitamin D is thought to be essential for normal brain development and modulation of the immune system. Worldwide about 1 billion people are affected by vitamin D deficiency.

• High-sensitivity C-reactive protein (hs-CRP),
• cytochrome P450 2E1 (CYP2E1) and
• 8-hydroxy-2′-deoxyguanosine (8-OH-dG)

are biomarkers related to inflammation and oxidative stress. In the present study, these biomarkers were together with serum 25-hydroxyvitamin D (25(OH)D3) analyzed in 28 (mean age seven years) Saudi male patients with ASD. The study was conducted to determine if there is any relationship between vitamin D levels, the tested biomarkers and the presence and severity of ASD. The hope was to identify if these biomarkers may be useful for early ASD diagnosis. The Childhood Autism Rating Scale (CARS) and the Social Responsiveness Scale (SRS) were used to measure autism severity.
The results of the ASD children were compared with 27 age and gender-matched neurotypical controls. The data indicated that Saudi patients with ASD have significantly lower plasma levels of 25(OH)D3 than neurotypical controls (38 ng/ml compared to 56 ng/ml, respectively; [P = 0.001]).
Surprisingly, the levels of CYP2E1 were lower in the children with ASD than the neurotypical controls (0.48 ± 0.08 vs. 69 ± 0.07 ng/ml, respectively; P = 0.001).
The ASD children also had significantly higher levels of hs-CRP (0.79 ± 0.09 vs. 0.59 ± 0.09 ng/ml, respectively; P = 0.001) and 8- OH-dG (8.17 ± 1.04 vs. 4.13 ± 1.01 ng/ml, respectively; P = 0.001, compared to neurotypical age and gender-matched controls.
The values for hs-CRP and 8- OH-dG did not correlate [P < 0.001] with autism severity.

There was found a relationship between autism severity on the CARS scale and the levels of 25(OH)D3 and CYP1B1. But this was not found for SRS. All four biomarkers seemed to have good sensitivity and specificity, but the sample size of the present study was too small to determine clinical usefulness. The findings also indicate that inadequate levels of vitamin D play a role in the etiology and severity of autism.

Furthermore, the results of the present study suggest the possibility of using 25(OH)D3, CYP1B1, hs-CRP and 8- OH-dG, preferably in combination, as biomarkers for the early diagnosis of ASD. However, further research is needed to evaluate this hypothesis.

Acknowledgements: This research project was supported by a grant from the Research Center of the Center for Female Scientific and Medical Colleges at King Saud University.

125 References

• ADDM Network-Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators (2014) Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63(2):1–21
• Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB, Puliyel JM (2002) The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Child 87:111–113
• Alfawaz HA, Shafi Bhat R, Al-Ayadhi L, El-Ansary AK (2014) Protective and restorative potency of Vitamin D on persistent biochemical autistic features induced in propionic acid-intoxicated rat pups. BMC Complement Altern Med 14:416. https://doi.org/10.1186/1472-6882-14-416
• Ali A, Cui X, Eyles D (2016) Developmental vitamin D deficiency and autism: putative pathogenic mechanisms. J Steroid Biochem Mol Biol. https://doi.org/10.1016/j.jsbmb.2016.12.018
• Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK (2011) Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol 11:139. https://doi.org/10.1186/1471-2377-11-139
• Anderson DK, Liang JW, Lord C (2014) Predicting young adult outcome among more and less cognitively able individuals with autism spectrum disorders. J Child Psychol Psychiatry 55:485–494
• APA-American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC
• Baïz N, Dargent-Molina P, Wark JD, Souberbielle JC, Slama R, Annesi-Maesano I, EDEN Mother-Child Cohort Study Group (2012) Gestational exposure to urban air pollution related to a decrease in cord blood vitamin D levels. J Clin Endocrinol Metab 97:4087–4095
• Baranek GT, Watson LR, Crais E, Reznick S (2003) First-Year Inventory (FYI) 2.0. University of North Carolina, Chapel Hill
• Bikle DD, Siiteri PK, Ryzen E et al (1985) Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 61:969–975
• Bjørklund G (2016) Vitamin D deficiency: a global health problem. Peertechz J Environ Sci Toxicol 1:23–24 https://www.peertechz.com/Environmental-Science-Toxicology/pdf/PJEST-1-104.pdf. Accessed 21 April 2017
• Bjørklund G, Saad K, Chirumbolo S, Kern JK, Geier DA, Geier MR, Urbina MA (2016) Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiol Exp (Wars) 76:257–268
• Bryson SE, Zwaigenbaum L, McDermott C, Rombough V, Brian J (2008) The autism observation scale for infants: scale development and reliability data. J Autism Dev Disord 38:731–738
• Calderón-Garcidueñas L, Wen-Wang L, Zhang YJ, Rodriguez-Alcaraz A, Osnaya N, Villarreal-Calderón A, Santella RM (1999) 8-hydroxy-2'-deoxyguanosine, a major mutagenic oxidative DNA lesion, and DNA strand breaks in nasal respiratory epithelium of children exposed to urban pollution. Environ Health Perspect 107:469–474
• Cannell JJ (2008) Autism and vitamin D. Med Hypotheses 70:750–759
• Cannell JJ (2013) Autism, will vitamin D treat core symptoms? Med Hypotheses 81:195–198
• Cannell JJ (2017) Vitamin D and autism, what’s new? Rev Endocr Metab Disord. https://doi.org/10.1007/s11154-017-9409-0
• Carpenter TO, Zhang JH, Parra E, Ellis BK, Simpson C, Lee WM, Balko J, Fu L, Wong BY, Cole DE (2013) Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone Miner Res 28:213–221
• Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, Banerjee-Basu S, Baron-Cohen S (2009) Genes Related to Sex Steroids, Neural Growth, and Social–Emotional Behavior are Associated with Autistic Traits, Empathy, and Asperger Syndrome. 9 International Society for Autism Research, Wiley Periodicals, Inc. p 1–21
• Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferring the antioxidant proteins. Life Sci 75:2539–2549
• Chen J, Xin K, Wei J, Zhang K, Xiao H (2016) Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J Psychosom Res 89:98–101
• Cherniack EP, Troen BR (2011) Vitamin D, cognitive function, and mental health. In: Benton D (ed) Lifetime nutritional influences on cognition, behaviour and psychiatric illness. Woodhead Publishing, Sawston, pp 420–438. https://doi.org/10.1533/9780857092922.3.420
• Chirumbolo S, Bjørklund G, Sboarina A, Vella A (2017) The role of vitamin D in the immune system as a pro-survival molecule. Clin Ther. https://doi.org/10.1016/j.clinthera.2017.03.021
• Christensen DL, Baio J, Van Naarden BK, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M, Centers for Disease Control and Prevention (CDC) (2016) Prevalence and characteristics of autism spectrum disorder among children aged 8 years--Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ 65(3):1–23. https://doi.org/10.15585/mmwr.ss6503a1
• Chun SK, Shin SA, Kim MY, Joung H, Chung J (2016) Effects of maternal genetic polymorphisms in vitamin D-binding protein and serum 25-hydroxyvitamin D concentration on infant birth weight. Nutrition 35:36–42. https://doi.org/10.1016/j.nut.2016.10.006
• Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, Metzger LM, Shoushtari CS, Splinter R, Reich W (2003) Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 33:427–433
• Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, Marques C, Ataíde A, Miguel T, Borges L, Vicente AM (2004) Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 9:264–271
• Currenti SA (2010) Understanding and determining the etiology of autism. Cell Mol Neurobiol 30:161–171
• Dawodu A, Wagner CL (2012) Prevention of vitamin D deficiency in mothers and infants worldwide - a paradigm shift. Paediatr Int Child Health 32:3–13
• Dawodu A, Zalla L, Woo JG, Herbers PM, Davidson BS, Heubi JE, Morrow AL (2014) Heightened attention to supplementation is needed to improve the vitamin D status of breastfeeding mothers and infants when sunshine exposure is restricted. Matern Child Nutr 10:383–397
• Delanghe JR, Speeckaert R, Speeckaert MM (2015) Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 29:773–786
• Dey A (2013) Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenario. Subcell Biochem 67:1–104
• Du L, Shan L, Wang B, Feng JY, Xu ZD, Jia FY (2015) Serum levels of 25-hydroxyvitamin D in children with autism spectrum disorders. Zhongguo Dang Dai Er Ke Za Zhi 17:68–71
• El-Ansary A (2016) Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief 7:111–116
• El-Ansary A, Al-Ayadhi L (2012) Neuroinflammation in autism spectrum disorders. J Neuroinflammation 9:265. https://doi.org/10.1186/1742-2094-9-265
• El-Ansary AK, Bacha AG, Al-Ayahdi LY (2011a) Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis 10:62. https://doi.org/10.1186/1476-511X-10-62
• El-Ansary A, Ben Bacha AG, Al-Ayadhi LY (2011b) Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia. J Neuroinflammation 8:142. https://doi.org/10.1186/1742-2094-8-142
• El-Ansary A, Hassan WM, Qasem H, Das UN (2016) Identification of biomarkers of impaired sensory profiles among autistic patients. PLoS One 11:e0164153. https://doi.org/10.1371/journal.pone.0164153
• Emond P, Mavel S, Aïdoud N et al (2013) GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem 405:5291–5300
• Fan X, Warner M, Gustafsson JA (2006) Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons. Proc Natl Acad Sci U S A. 103:19338–19343
• Fedirko V, Bostick RM, Long Q, Flanders WD, Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML, Sidelnikov E et al (2010) Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 19:280–291
• Ferguson CS, Tyndale RF (2011) Cytochromes P450 in the brain: Emerging evidence for biological significance. Trends Pharmacol Sci 32:708–714
• Fernell E, Bejerot S, Westerlund J, Miniscalco C, Simila H, Eyles D, Gillberg C, Humble MB (2015) Autism spectrum disorder and low vitamin D at birth: a sibling control study. Mol Autism 6:3. https://doi.org/10.1186/2040-2392-6-3
• Fukuda M, Yamaguchi H, Yamamoto H, Aminaka M, Muramaka H, Kamiyama N et al (2008) The evaluation of oxidative stress damage in children with brain damage using 8 OH deoxyguanosine levels. Brain Dev 30:131–136
• Garcion E, Thanh XD, Bled F, Teissier E, Dehouck MP, Rigault F, Brachet P, Girault A, Torpier G, Darcy F (1996) 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neurosci Lett 216:183–186
• Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100–105
• Ghanizadeh A, Akhondzadeh S, Hormozi M, Makarem A, Abotorabi-Zarchi M, Firoozabadi A (2012) Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem 19:4000–4005
• Gies P, Makin J, Dobbinson S, Javorniczky J, Henderson S, Guilfoyle R, Lock J (2013) Shade provision for toddlers at swimming pools in Melbourne. Photochem Photobiol 89:968–973
• Gong ZL, Luo CM, Wang L, Shen L, Wei F, Tong RJ, Liu Y (2014) Serum 25-hydroxyvitamin D levels in chinese children with autism spectrum disorders. Neuroreport 25:23–27
• Gonzalez-Suarez I, Redwood AB, Grotsky DA, Neumann MA, Cheng EH, Stewart CL, Dusso A, Gonzalo S (2011) A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair. EMBO J 30:3383–3396. https://doi.org/10.1038/emboj.2011.225
• Gordon-Thomson C, Gupta R, Tongkao-on W, Ryan A, Halliday GM, Mason RS (2012) 1α,25 Dihydroxyvitamin D3 enhances cellular defenses against UV-induced oxidative and other forms of DNA damage in skin. Photochem Photobiol Sci 11:1837–1847
• Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S (2016) Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Oncogene 35:5362–5376
• Griffin MD, Xing N, Kumar R (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23:117–145
• Gross ML, Tenenbein M, Sellers EA (2013) Severe vitamin D deficiency in 6 Canadian first nation formula-fed infants. Int J Circumpolar Health 72:20244. https://doi.org/10.3402/ijch.v72i0.20244
• Helbock HJ, Beckman KB, Ames BN (1999) 8 hydroxy deoxyguanosine and 8hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol 300:156–166
• Hodgson NW, Waly MI, Al-Farsi YM, Al-Sharbati MM, Al-Farsi O, Ali A, Ouhtit A, Zang T, Zhou ZS, Deth RC (2014) Decreased glutathione and elevated hair mercury levels are associated with nutritional deficiency-based autism in Oman. Exp Biol Med (Maywood) 239:697–706
• Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062–2072
• Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
• Hosseinpanah F, Pour SH, Heibatollahi M, Moghbel N, Asefzade S, Azizi F (2010) The effects of air pollution on vitamin D status in healthy women: a cross sectional study. BMC Public Health 10:519. https://doi.org/10.1186/1471-2458-10-519
• Huang Y, Sullivan Pepe M, Feng Z (2007) Evaluating the predictiveness of a continuous marker. Biometrics. 63(4):1181–1188
• Jacob A, Zhou M, Wu R, Wang P (2009) The role of hepatic cytochrome P-450 in sepsis. Int J Clin Exp Med 2:203–211
• Jain SK, Micinski D (2013) Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun 437:7–11
• James SJ (2013) Autism and folate-dependent one-carbon metabolism: serendipity and critical branch-point decisions in science. Glob Adv Health Med 2:48–51
• James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611–1617
• Jiménez-Garza O, Baccarelli AA, Byun HM, Márquez-Gamiño S, Barrón-Vivanco BS, Albores A (2015) CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: Relationship with oxidative stress and smoking habit. Toxicol Appl Pharmacol 286:207–215
• Jones KS, Assar S, Vanderschueren D, Bouillon R, Prentice A, Schoenmakers I (2015) Predictors of 25(OH)D3 half-life and plasma 25(OH)D3 concentration in Gambia and the UK. Osteoporos Int 26:1137–1146
• Kelishadi R, Moeini R, Poursafa P, Farajian S, Yousefy H, Okhovat-Souraki AA (2014) Independent association between air pollutants and vitamin D deficiency in young children in Isfahan, Iran. Paediatr Int Child Health 34:50–55
• Khakzad MR, Javanbakht M, Shayegan MR, Kianoush S, Omid F, Hojati M, Meshkat M (2012) The complementary role of high sensitivity C-reactive protein in the diagnosis and severity assessment of autism. Res Autism Spectr Disord 6:1032–1037
• Kinney DK, Barch DH, Chayka B, Napoleon S, Munir KM (2010) Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder? Med Hypotheses 74:102–106
• Kouzmenko A, Ohtake F, Fujiki R, Kato S (2010) Hormonal gene regulation through DNA methylation and demethylation. Epigenomics 2:765–774
• Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Kano Y, Kasai K (2013) Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study. PLoS ONE 8:e73814. https://doi.org/10.1371/journal.pone.0073814
• Lai JK, Lucas RM, Banks E, Ponsonby AL (2012) Ausimmune investigator group. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 42:43–50
• Lakhdar H, Zouhair K, Khadir K, Essari A, Richard A, Seité S, Rougier A (2007) Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol 21:738–742
• Lanphear BP (2015) The impact of toxins on the developing brain. Annu Rev Public Health 36:211–230
• Lin XF, Wang ZY, Feng WJ (2015) Influence of drug-metabolizing enzymes by autism treatment drug haloperidol. Latin American Journal of Pharmacy 34:1693–1696
• Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS et al (2012) Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology 79:267–273
• Magnusson C, Lundberg M, Lee BK, Rai D, Karlsson H, Gardner R, Kosidou K, Arver S, Dalman C (2016) Maternal vitamin D deficiency and the risk of autism spectrum disorders: population-based study. BJPsych Open 2:170–172
• Mahmoud AA, Ali AH (2014) Vitamin D receptor gene polymorphism and 25 hydroxy vitamin D levels in Egyptian patients with pulmonary tuberculosis. Egypt J Chest Dis Tuberc 63:651–655
• Marusteri M, Bacarea V (2010) Comparing groups for statistical differences: how to choose the right statistical test? Biochemia Medica 20:15–32
• Mazahery H, Camargo CA, Conlon C, Beck KL, Kruger MC, von Hurst PR (2016) Vitamin D and autism spectrum disorder: a literature review. Nutrients 8:236. https://doi.org/10.3390/nu8040236
• Mellenthin L, Wallaschofski H, Grotevendt A, Völzke H, Nauck M, Hannemann A (2014) Association between serum vitamin D concentrations and inflammatory markers in the general adult population. Metabolism 63:1056–1062
• Mick KA (2005) Diagnosing autism: Comparison of the Childhood Autism Rating Scale (CARS) and the Autism Diagnostic Observation Schedule (ADOS). Dissertation, Wichita State University
• Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC (2005) Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73:379–384
• Ming X, Stein TP, Barnes V et al (2012) Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 11:5856–5862
• Mostafa GA, Al-Ayadhi LY (2012) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation 9:201. https://doi.org/10.1186/1742-2094-9-201
• Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155–1162
• Olmos-Ortiz A, García-Quiroz J, López-Marure R, González-Curiel I, Rivas-Santiago B, Olivares A, Avila E, Barrera D, Halhali A, Caldiño F, Larrea F, Díaz L (2016) Evidence of sexual dimorphism in placental vitamin D metabolism: Testosterone inhibits calcitriol-dependent cathelicidin expression. J Steroid Biochem Mol Biol 163:173–182
• Patrick RP, Ames BN (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 28:2398–2413
• Pelphrey K (2017) Charting a course for autism biomarkers. Biol Psychiatry 82:155–156
• Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y (2008) Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol. 167:362–368
• Piao SG, Song JC, Lim SW, Chung BH, Choi BS, Yang CW (2012) Protective effect of paricalcitol on cyclosporine-induced renal injury in rats. Transplant Proc 44:642–645
• Prabhulkar S, Li CZ (2010) Assessment of oxidative DNA damage and repair at single cellular level via real-time monitoring of 8- OHdG biomarker. Biosens Bioelectron 26:1743–1749
• Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, James SJ (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 10:e134. https://doi.org/10.1038/tp.2012.61
• Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, Abdel-Reheim MK, Othman HA, El-Houfey AA, Abd El-Aziz NH, Abd El-Baseer KA, Ahmed AE, Ali AM (2016a) Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci 19:346–351
• Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, El-Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina MA, Abo-Elela MG, Ahmad FA, Abd El-Baseer KA, Ahmed AE, Abdel-Salam AM (2016b) Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry. https://doi.org/10.1111/jcpp.12652
• Sajdel-Sulkowska E, Lipinski B, Windom H, Audhya J, Mc Ginis W (2008) Oxidative stress in autism: cerebelar 3 nitroryrosine levels. Am J Biochem Biotechnol 4:73–84
• Sajdel-Sulkowska EM, Xu M, Koibuchi N (2009) Increase in cerebellar 3-neurotrophin and oxidative stress markers in autism. Cerebellum 8:366–372
• Salhia HO, Al-Nasser LA, Taher LS, Al-Khathaami AM, El-Metwally AA (2014) Systemic review of the epidemiology of autism in Arab Gulf countries. Neurosciences (Riyadh) 19:291–296
• Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T (2012) Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Neuroepidemiology 39:84–93
• Schuster I (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814:186–199
• Singh VK (2005) Elevation of serum c-reactive protein and s100 proteins for systemic inflammation in autistic children. J Spec Educ Rehab 6:117–135
• Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N (2014) The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. J Neuroinflammation 11:78. https://doi.org/10.1186/1742-2094-11-78
• Stone WL, Coonrod EE, Turner LM, Pozdol SL (2004) Psychometric properties of the STAT for early autism screening. J Autism Dev Disord 34:691–701
• Thompson PD, Jurutka PW, Whitfield GK, Myskowski SM, Eichhorst KR, Dominguez CE, Haussler CA, Haussler MR (2002) Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res Commun 299:730–738
• Turner-Brown LM, Baranek GT, Reznick JS, Watson LR, Crais ER (2013) The first year inventory: a longitudinal follow-up of 12-montholds to 3 years of age. Autism 17:527–540
• Vanlint S, Nugent M (2006) Vitamin D and fractures in people with intellectual disability. J Intellect Disabil Res 50(Pt 10):761–767. https://doi.org/10.1111/j.1365-2788.2006.00841.x
• Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 26(6):565–574
• Vieira SE (2015) The health burden of pollution: the impact of prenatal exposure to air pollutants. Int J Chron Obstruct Pulmon Dis 10:1111–1121
• Vinkhuyzen AA, Eyles DW, Burne TH, Blanken LM, Kruithof CJ, Verhulst F, Jaddoe VW, Tiemeier H, McGrath JJ (2016) Gestational vitamin D deficiency and autism-related traits: the Generation R Study. Mol Psychiatry. https://doi.org/10.1038/mp.2016.213
• Walker RB, Conn JA, Davies MJ, Moore VM (2006) Mothers’ views on feeding infants around the time of weaning. Public Health Nutr 9:707–713
• Wang Z, Schuetz EG, Xu Y, Thummel KE (2013) Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J Steroid Biochem Mol Biol 136:54–58. https://doi.org/10.1016/j.jsbmb.2012.09.012
• Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F (2016) Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 25:341–350
• Watson LR, Baranek GT, Crais ER, Steven RJ, Dykstra J, Perryman T (2007) The first year inventory: retrospective parent responses to a questionnaire designed to identify one-year-olds at risk for autism. J Autism Dev Disord 37:49–61
• Wegienka G, Kaur H, Sangha R, Cassidy-Bushrow AE (2016) Maternal-cord blood Vitamin D correlations vary by maternal levels. J Pregnancy 2016:7474192. https://doi.org/10.1155/2016/7474192
• Werner E, Dawson G (2005) Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 62:889–895
• Wikvall K (2001) Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 7:201–209
• Windham GC, Zhang L, Gunier R, Croen LA, Grether JK (2006) Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 114:1438–1444
• Xu XJ, Shou XJ, Li J, Jia MX, Zhang JS, Guo Y, Wei QY, Zhang XT, Han SP, Zhang R, Han JS (2013) Mothers of autistic children: lower plasma levels of oxytocin and Arg-vasopressin and a higher level of testosterone. PLoS One 8:e74849. https://doi.org/10.1371/journal.pone.0074849
• Yang CJ, Liu CL, Sang B, Zhu XM, Du YJ (2015) The combined role of serotonin and interleukin-6 as biomarker for autism. Neuroscience 284:290–296
• Yui K, Tanuma N, Yamada H, Kawasaki Y (2016) Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder. Int J Dev Neurosci. https://doi.org/10.1016/j.ijdevneu.2016.08.003
• Yusuf A, Elsabbagh M (2015) At the cross-roads of participatory research and biomarker discovery in autism: the need for empirical data. BMC Med Ethics 16:88. https://doi.org/10.1186/s12910-015-0082-0
• Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ (2015) Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report 87:1–20
• Zaky EA, Fouda EM, Algohary EA, Al-Shony ES (2015) Prevalence of autism spectrum disorders in vitamin D deficient or insufficient rickets. Int J Sci Res (Raipur) 4:1365–1373
• Zhang Q, Cheng Y, He M, Li T, Ma Z, Cheng H (2016) Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial. Exp Ther Med 12:1889–1895